Sort   by:  
 Page size 
TranscriptomicsTranscriptional analysis of prefrontal area 9 in Parkinson's disease
Post mortem tissue was dissected from two groups of age and gender matched groups of Parkinson and Control subjects Published work contains more information on Parkinson and Control groups
ORGANISM(S): Homo sapiens 
2010-02-22 | E-GEOD-20168 | biostudies-arrayexpress
TranscriptomicsTranscriptional analysis of putamen in Parkinson's disease
Post mortem tissue was dissected from two groups of age and gender matched groups of Parkinson and Control subjects Published work contains more information on Parkinson and Control groups
ORGANISM(S): Homo sapiens 
2010-03-23 | E-GEOD-20291 | biostudies-arrayexpress
TranscriptomicsTranscriptional analysis of whole substantia nigra in Parkinson's disease
Post mortem tissue was dissected from two groups of age and gender matched groups of Parkinson and Control subjects Published work contains more information on Parkinson and Control groups
ORGANISM(S): Homo sapiens 
2010-03-23 | E-GEOD-20292 | biostudies-arrayexpress
UnknownA potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells.
Not available
S-EPMC10774440 | biostudies-literature
UnknownThe BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort.
Not available
S-EPMC5021110 | biostudies-literature
UnknownImpact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory Study.
Not available
S-EPMC10272925 | biostudies-literature
UnknownPredictive value of abbreviated olfactory tests in prodromal Parkinson disease.
Not available
S-EPMC10310835 | biostudies-literature
UnknownCytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease.
Not available
S-EPMC8248172 | biostudies-literature
GenomicsInternational Genetics of Parkinson Disease Progression (IGPP) Consortium GWAS Summary Results
To characterize how genetic variation influences the progression of Parkinson’s disease to dementia, which is a major determinant for quality of life, we performed a longitudinal genome-wide survival study (GWSS). Risk profile analysis was performed with a novel polygenic hazard score in longit...
EGAS00001005110 | EGA
Unknownα4β2* Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait-Balance Disorders.
Not available
S-EPMC9013471 | biostudies-literature
Sort   by:  
 Page size